Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

GSK plc announced the marketing authorisation of Exdensur (depemokimab) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Exdensur is now approved in two indications: ...

This article first appeared on GuruFocus. Analysts are increasingly focusing on GSK (NYSE:GSK) after Europe's drug regulator delivered what could be a pivotal endorsement for depemokimab, a treatment ...

A digital, noninvasive home‑monitoring system — integrating home spirometry, smartwatch data, and medical feedback — showed promise for managing pediatric asthma. Nocturnal heart rate monitoring was ...

Please provide your email address to receive an email when new articles are posted on . The median number of likes on accurate TikToks about asthma was smaller than that of inaccurate ones. Videos on ...

Jessica is a former writer and editor at Forbes Health with over a decade of experience in both lifestyle and clinical health topics. Before Forbes Health, Jessica was an editor for Healthline Media, ...

“It’s heartbreaking,” says Velontafa Jackia, a doctor based in Sambava, in the north-east of Madagascar. Until this year she was part of a project funded by the United States Agency for International ...

WASHINGTON, Sept 24 (Reuters) - The Trump administration intends to shift $1.8 billion in foreign aid funding toward "America First" initiatives such as pursuing investments in Greenland and ...

Saturday’s star-studded concert will air on TV for the first time in years as the hotline for farmers gets more calls about a mix of complicated problems. By Kevin Draper There was never supposed to ...

Weight loss injections could help to reduce asthma symptoms in obese people, according to researchers at the University of Aberdeen. The study by an international team of scientists found as well as ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head ...

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints Dupixent also outperformed Xolair ...